Chewy (CHWY)

NYSEConsumer DiscretionarySpecialty RetailSnapshot 2026-10-23

$21.93-1.79%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Chewy’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

+0.2%

+10% or more+5%0%−5%−10% or less

1.06 → 1.07 EPS · FY ending Feb 1, 2028 · 15 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 24, 2026 to Oct 24, 2026: (new ÷ prior − 1). Contributor count changed from 15 to 15; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-11-02
Revenue	—	3.34B
EPS	—	0.19
Quarter ending 2027-01-31
Revenue	—	3.49B
EPS	—	0.356
Annual ending 2027-02-01
Revenue	—	13.53B
EPS	—	0.776
Annual ending 2028-02-01
Revenue	—	14.44B
EPS	—	1.066

Management figures unavailable.

What the Thesis Depends On

4 published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Cash from operations at least $263.4 million	The company is expanding gross margin and increasing cash from operations.	Intact	cash from operations falls below $133.9 million	Cash from operations: $137.4M FY2026-Q2; GAAP. Published target: >=263.4 million USD. The stored target says 2025-Q4; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Source published Sep 9, 2026137,400,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Aug 2, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Gross margin at or above 30.1%	The company is expanding gross margin and increasing cash from operations.	Intact	gross margin falls below 29.6% (mid-cycle level)	Gross margin: 30.36% FY2026-Q2; GAAP. Published target: >=30.1%. The target does not explicitly identify fiscal versus calendar quarters. Source published Sep 9, 202630.364543 percent · calculatedSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Aug 2, 2026 Source: company_financial_results. Reference: f33781dd-01af-4bff-8e95-8e46d3aa9507. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 of last 3 quarters. Gross margin expanded from 29.8% in 2025 to 30.4% in 2026-Q3, and operating income increased from $69.7M in 2025-Q3 to $92.0M in 2026-Q3. Management's focus on margin expansion and efficiency is showing delivering results. Delivery assessment Oct 24, 2026
Net income growth to at least $94.8 million	Net income rose to $94.8 million in Q2 2026.	Intact	net income falls below $62.4 million	Net income: $80.5M FY2026-Q2; GAAP. Published target: >=94.8 million USD. The target does not explicitly identify fiscal versus calendar quarters. Source published Sep 9, 202680,500,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Aug 2, 2026 Source: company_financial_results. Reference: f33781dd-01af-4bff-8e95-8e46d3aa9507. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Revenue growth of at least 7.9% annually	A primary condition in Chewy's published investment case. The stated target is >=7.9% YoY.	Broken	YoY revenue growth falls below 7.9% next year	Revenue growth: 7.28% FY2026-Q2; GAAP. Published target: >=7.9% YoY. Target period is not explicitly aligned with this observation. Source published Sep 9, 20267.280459 percent · calculatedSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Aug 2, 2026 Source: company_financial_results. Reference: f33781dd-01af-4bff-8e95-8e46d3aa9507. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2028 · fiscal year ending 2028-02-01 · fmp

FY2028 EPS$1.07

$1.09 → $1.07 · observed estimates

FY2028 revenue$14.44B

$14.45B → $14.44B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2028 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$1.09	$14,445,318,430	14 / 19
2026-07-25	$1.09	$14,445,318,430	14 / 19
2026-07-26	$1.09	$14,445,318,430	14 / 19
2026-07-27	$1.09	$14,445,318,430	14 / 19
2026-07-28	$1.09	$14,445,318,430	14 / 19
2026-07-29	$1.09	$14,445,318,430	14 / 19
2026-07-30	$1.09	$14,441,127,531	14 / 19
2026-07-31	$1.09	$14,441,127,531	14 / 19
2026-08-01	$1.09	$14,441,127,531	14 / 19
2026-08-02	$1.09	$14,441,127,531	14 / 19
2026-08-03	$1.08	$14,434,327,531	14 / 19
2026-08-04	$1.08	$14,434,327,531	14 / 19
2026-08-05	$1.08	$14,434,327,531	14 / 19
2026-08-06	$1.08	$14,434,327,531	14 / 19
2026-08-07	$1.08	$14,434,327,531	14 / 19
2026-08-08	$1.08	$14,434,327,531	14 / 19
2026-08-09	$1.08	$14,434,327,531	14 / 19
2026-08-10	$1.08	$14,434,327,531	14 / 19
2026-08-11	$1.08	$14,434,327,531	14 / 19
2026-08-12	$1.08	$14,434,327,531	14 / 19
2026-08-13	$1.08	$14,434,327,531	14 / 19
2026-08-14	$1.08	$14,434,327,531	14 / 19
2026-08-15	$1.08	$14,434,327,531	14 / 19
2026-08-16	$1.08	$14,434,327,531	14 / 19
2026-08-17	$1.08	$14,434,327,531	14 / 19
2026-08-18	$1.08	$14,434,327,531	14 / 19
2026-08-19	$1.08	$14,434,327,531	14 / 19
2026-08-20	$1.08	$14,434,327,531	14 / 19
2026-08-21	$1.08	$14,432,794,430	15 / 19
2026-08-22	$1.08	$14,432,794,430	15 / 19
2026-08-23	$1.08	$14,432,794,430	15 / 19
2026-08-24	$1.08	$14,432,794,430	15 / 19
2026-08-25	$1.08	$14,432,794,430	15 / 19
2026-08-26	$1.08	$14,432,794,430	15 / 19
2026-08-27	$1.08	$14,432,794,430	15 / 19
2026-08-28	$1.08	$14,426,939,466	15 / 19
2026-08-29	$1.08	$14,426,939,466	15 / 19
2026-08-30	$1.08	$14,426,939,466	15 / 19
2026-08-31	$1.08	$14,426,939,466	15 / 19
2026-09-01	$1.08	$14,426,939,466	15 / 19
2026-09-02	$1.08	$14,426,939,466	15 / 19
2026-09-03	$1.08	$14,426,967,466	15 / 19
2026-09-04	$1.08	$14,426,967,466	15 / 19
2026-09-05	$1.08	$14,426,967,466	15 / 19
2026-09-06	$1.08	$14,413,854,798	15 / 19
2026-09-07	$1.08	$14,413,854,798	15 / 19
2026-09-08	$1.08	$14,413,854,798	15 / 19
2026-09-09	$1.08	$14,413,855,630	15 / 19
2026-09-10	$1.07	$14,427,702,616	15 / 19
2026-09-11	$1.07	$14,430,734,910	15 / 19
2026-09-12	$1.07	$14,434,334,910	15 / 19
2026-09-13	$1.07	$14,434,334,910	15 / 19
2026-09-14	$1.07	$14,434,334,910	15 / 19
2026-09-15	$1.07	$14,434,334,910	15 / 19
2026-09-16	$1.07	$14,434,334,910	15 / 19
2026-09-17	$1.07	$14,434,334,910	15 / 19
2026-09-18	$1.07	$14,434,334,910	15 / 19
2026-09-19	$1.06	$14,434,334,910	15 / 19
2026-09-20	$1.06	$14,434,338,870	15 / 19
2026-09-21	$1.06	$14,434,338,870	15 / 19
2026-09-22	$1.06	$14,434,334,910	15 / 19
2026-09-23	$1.06	$14,434,334,910	15 / 19
2026-09-24	$1.06	$14,434,334,910	15 / 19
2026-09-25	$1.06	$14,434,334,910	15 / 19
2026-09-26	$1.06	$14,434,334,910	15 / 19
2026-09-27	$1.06	$14,434,334,910	15 / 19
2026-09-28	$1.06	$14,434,334,910	15 / 19
2026-09-29	$1.06	$14,434,334,910	15 / 19
2026-09-30	$1.06	$14,439,185,666	15 / 19
2026-10-01	$1.06	$14,439,174,910	15 / 19
2026-10-02	$1.06	$14,439,174,910	15 / 19
2026-10-03	$1.06	$14,439,174,910	15 / 19
2026-10-04	$1.06	$14,439,166,910	15 / 19
2026-10-05	$1.06	$14,439,166,910	15 / 19
2026-10-06	$1.06	$14,439,166,910	15 / 19
2026-10-07	$1.06	$14,439,166,910	15 / 19
2026-10-08	$1.07	$14,439,166,910	15 / 19
2026-10-09	$1.07	$14,439,166,910	15 / 19
2026-10-10	$1.07	$14,439,163,218	15 / 19
2026-10-11	$1.07	$14,439,163,218	15 / 19
2026-10-12	$1.07	$14,439,163,218	15 / 19
2026-10-13	$1.07	$14,439,163,218	15 / 19
2026-10-14	$1.07	$14,439,163,218	15 / 19
2026-10-15	$1.07	$14,439,163,218	15 / 19
2026-10-16	$1.07	$14,439,163,218	15 / 19
2026-10-17	$1.07	$14,439,163,218	15 / 19
2026-10-18	$1.07	$14,439,173,974	15 / 19
2026-10-19	$1.07	$14,439,173,974	15 / 19
2026-10-20	$1.07	$14,439,493,974	15 / 19
2026-10-21	$1.07	$14,439,493,974	15 / 19
2026-10-22	$1.07	$14,439,493,974	15 / 19
2026-10-23	$1.07	$14,439,493,974	15 / 19
2026-10-24	$1.07	$14,439,493,974	15 / 19

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	21	5
2026-06-01	20	5
2026-07-01	20	5
2026-08-01	20	6
2026-09-01	20	8
2026-10-01	18	8

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 18 Buy / Strong Buy · 8 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades1 maintains

Recent actions · Sep 25–Oct 24 · 1 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

Mizuho SecuritiesSep 29 · prior Sep 4

$32.00 → $28.00-12.5%

$0$17.60$35.20

0 raises · 1 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Cash from operations at least $263.4 millionCash from operations: $137.4M
Gross margin at or above 30.1%Gross margin: 30.36%
Net income growth to at least $94.8 millionNet income: $80.5M
Revenue growth of at least 7.9% annuallyPublished status: Broken

Next proof point

Dec 9, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.9%Typical daily move · historical

Downside history

-51.7%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Chewy outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

This is a profitable-growth business with a multi-year thesis built on expanding margins, better efficiency, and stronger cash flow. The thesis is intact, with recent financial performance in the top half of its industry, but confidence is medium and risk is elevated.

What's priced into Chewy

The valuation is expensive versus peers, with a 1.63 premium, while the expectations gap is negative at -0.13. The priced-in assessment is tagged as justified and fragility is low, but that does not remove the risk that expectations are difficult to meet.

What the fundamentals likely do

Near-term results show progress: sales, adjusted EBITDA margin, and net income rose between 2026-Q1 and 2026-Q3, while gross margin and operating income also improved. Management’s priorities remain on track, and free cash flow reached a record in fiscal 2025, but a September earnings miss and a run of recent misses create execution risk.

What Chewy hinges on

The multi-year thesis depends on management continuing to expand margins, improve efficiency, and generate cash flow. Near term, a guidance cut on the next call would be a meaningful negative; stronger or weaker results and guidance from sector bellwethers could also shape the consumer-discretionary backdrop.